DR. MICHAEL DAUCHOT joined Dresdner RCM Global Investors in 1999 as an
Analyst in the healthcare group, focusing on medical technology and
emerging pharmaceuticals. Prior to joining the firm, he was a Junior
Analyst in the healthcare industry at BancBoston Robertson Stephens,
where he also specialized in medical technology and diagnostic
companies. He graduated from Case Western Reserve University, Phi Beta
Kappa and magna cum laude, with a degree in Chemistry before earning his
MD from the University of Cincinnati College of Medicine. Dr. Dauchot
earned his MBA from the JL Kellogg School of Management at Northwestern
University.
